Literature DB >> 20442544

Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension.

Banashree Mandal1, Poonam Malhotra Kapoor, Ujjwal Chowdhury, Usha Kiran, Minati Choudhury.   

Abstract

OBJECTIVES: The presence of pulmonary artery hypertension (PAH) affects the prognosis of patients; therefore, it is important to treat it. The aim of this study is to compare the acute hemodynamic effects of inhaled nitroglycerine (iNTG), intravenous nitroglycerine (IV NTG) alone and their combination with intravenous dobutamine (IV DOB) during the early postoperative period, in patients with PAH undergoing mitral valve or double valve replacement surgery.
MATERIALS AND METHODS: In the study, 40 patients with secondary PAH were administered iNTG 2.5 microg/kg/min, IV NTG 2.5 microg/kg/min, a combination of iNTG 2.5 microg/kg/min + IV DOB 10 microg/kg/min, and IV NTG 2.5 microg/kg/min + IV DOB 10 microg/kg/min for 10 minutes each following valve replacement surgery, in random order. The hemodynamic parameters were recorded before (T0) and immediately after the intervention. (T1).
RESULTS: iNTG effectively decreased mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance index (PVRI), and the PVR / SVR ratio, without affecting arterial pressures, systemic vascular resistance or mixed venous oxygen saturation (SvO2). IV NTG produced both systemic and pulmonary vasodilation along with a significant fall in SvO2. The combination of iNTG and IV DOB caused a significant decrease in mPAP and PVRI, with no significant change in SVRI, PVR / SVR ratio, and SvO2. A combination of IV NTG + IV DOB caused both pulmonary and systemic vasodilatation with a significant decrease in SvO2. None of the drugs caused any significant change in the cardiac index.
CONCLUSION: All drugs were of similar efficacy in reducing the pulmonary vascular resistance index. Only iNTG produced selective pulmonary vasodilatation, while IV NTG and its combination with IV dobutamine had a significant concomitant systemic vasodilatory effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442544     DOI: 10.4103/0971-9784.62946

Source DB:  PubMed          Journal:  Ann Card Anaesth        ISSN: 0971-9784


  6 in total

Review 1.  Pharmacologic management of perioperative pulmonary hypertension.

Authors:  Julie W Cheng; Adriano R Tonelli; Gosta Pettersson; Richard A Krasuski
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

2.  Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery.

Authors:  Abdelhay A Ebade; Mohamed A Khalil; Ahmed K Mohamed
Journal:  J Anesth       Date:  2012-12-09       Impact factor: 2.078

3.  Pulmonary circulatory changes after bilateral total knee arthroplasty during regional anesthesia.

Authors:  Anna Maria Bombardieri; Stavros G Memtsoudis; George Go; Yan Ma; Thomas Sculco; Nigel Sharrock
Journal:  J Clin Anesth       Date:  2013-02       Impact factor: 9.452

4.  Evaluating hemodynamic outcomes of different dosages of intravenous nitroglycerin after coronary artery bypass graft surgery.

Authors:  Gholamreza Masoumi; Evaz Hidarpour; Ali Sadeghpour Tabae; Mohsen Ziayeefard; Atosa Azarasa; Amin Abneshahidi; Sanam Javid Anbardan; Parviz Kashefi
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

Review 5.  Inhaled therapy for the management of perioperative pulmonary hypertension.

Authors:  C A Thunberg; S T Morozowich; Harish Ramakrishna
Journal:  Ann Card Anaesth       Date:  2015 Jul-Sep

6.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Perioperative management in patients with pulmonary hypertension.

Authors:  Adriano R Tonelli; Omar A Minai
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.